Literature DB >> 8832585

Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction.

Y Ikeda1, M Nishimoto, Y Shimazu, H Hashimoto, K Umemura, M Nakashima.   

Abstract

We studied the effects of fluvoxamine and amitriptyline on epicardial activation delay of premature excitations, the effective refractory period, and the incidence of ventricular arrhythmias by programmed electrical ventricular stimulation in the canine heart after myocardial infarction. Additionally, we investigated whether the inhibition of norepinephrine reuptake by amitriptyline contributes to epicardial activation delay or arrhythmias by combination with propranolol pretreatment. Amitriptyline, at a dose of 3 mg/kg, significantly prolonged epicardial activation delay of premature excitations in the infarcted zone in a frequency-dependent manner (n = 10). Amitriptyline also prolonged epicardial activation delay of premature excitations in the normal zone (n = 10). The effective refractory period in the infarcted zone was significantly prolonged by amitriptyline at a dose of 3 mg/kg (n = 8). Amitriptyline increased the incidence of ventricular arrhythmias induced by programmed electrical ventricular stimulation (n = 8). Propranolol did not affect the epicardial activation delay caused by amitriptyline or the incidence of ventricular arrhythmias induced by programmed electrical ventricular stimulation (n = 6). Fluvoxamine, on the other hand, had no significant effect on epicardial activation delay of premature excitations (n = 10) or the effective refractory period (n = 8) in both the infarcted and normal zones. Fluvoxamine did not increase the incidence of ventricular arrhythmias induced by programmed electrical ventricular stimulation (n = 8).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832585     DOI: 10.1007/bf00168703

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  Cardiac instability amplified by use-dependent Na channel blockade.

Authors:  C F Starmer; A R Lancaster; A A Lastra; A O Grant
Journal:  Am J Physiol       Date:  1992-04

3.  Delayed development of ventricular ectopic rhythms following experimental coronary occlusion.

Authors:  A S HARRIS
Journal:  Circulation       Date:  1950-06       Impact factor: 29.690

4.  A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake.

Authors:  B Harper; I E Hughes
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

Review 5.  Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.

Authors:  J B Marshall; A D Forker
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

6.  Comparative effects of antidepressants, amitriptyline, and maprotiline on intraventricular conduction, effective refractory period, and incidence of ventricular arrhythmias induced by programmed stimulation in dog hearts after myocardial infarction.

Authors:  H Hashimoto; M Nishimoto; T Ozaki; K Oohara; M Nakashima
Journal:  J Cardiovasc Pharmacol       Date:  1990-11       Impact factor: 3.105

Review 7.  Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies.

Authors:  S P Roose; A H Glassman
Journal:  J Clin Psychiatry       Date:  1994-09       Impact factor: 4.384

8.  Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps.

Authors:  W B Gough; R Mehra; M Restivo; R H Zeiler; N el-Sherif
Journal:  Circ Res       Date:  1985-09       Impact factor: 17.367

9.  Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine.

Authors:  J C Roos
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  Review of the animal pharmacology and pharmacokinetics of fluvoxamine.

Authors:  V Claassen
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.